Pflug Koory LLC Sells 4,950 Shares of CVS Health Co. (NYSE:CVS)

Pflug Koory LLC lessened its holdings in shares of CVS Health Co. (NYSE:CVSFree Report) by 31.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,733 shares of the pharmacy operator’s stock after selling 4,950 shares during the period. Pflug Koory LLC’s holdings in CVS Health were worth $482,000 at the end of the most recent quarter.

A number of other large investors have also bought and sold shares of CVS. APG Asset Management N.V. raised its holdings in shares of CVS Health by 0.9% during the second quarter. APG Asset Management N.V. now owns 1,108,877 shares of the pharmacy operator’s stock worth $61,106,000 after acquiring an additional 10,096 shares during the period. Dark Forest Capital Management LP bought a new stake in shares of CVS Health in the second quarter valued at about $422,000. MBB Public Markets I LLC boosted its position in shares of CVS Health by 1,770.3% during the second quarter. MBB Public Markets I LLC now owns 90,297 shares of the pharmacy operator’s stock worth $5,333,000 after buying an additional 85,469 shares during the period. The Manufacturers Life Insurance Company grew its holdings in shares of CVS Health by 3.2% during the second quarter. The Manufacturers Life Insurance Company now owns 1,017,106 shares of the pharmacy operator’s stock worth $60,070,000 after buying an additional 31,966 shares in the last quarter. Finally, Susquehanna Fundamental Investments LLC lifted its stake in CVS Health by 27.9% in the 2nd quarter. Susquehanna Fundamental Investments LLC now owns 665,451 shares of the pharmacy operator’s stock valued at $39,302,000 after acquiring an additional 145,158 shares in the last quarter. 80.66% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on the stock. Mizuho cut their price objective on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a research report on Thursday, October 24th. Evercore ISI raised their price objective on CVS Health from $62.00 to $75.00 and gave the company an “outperform” rating in a report on Tuesday, October 8th. Barclays reduced their price target on CVS Health from $75.00 to $71.00 and set an “overweight” rating for the company in a research report on Thursday, November 7th. Truist Financial dropped their price objective on CVS Health from $67.00 to $60.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Finally, Royal Bank of Canada lowered their target price on shares of CVS Health from $68.00 to $58.00 and set an “outperform” rating on the stock in a report on Friday, November 15th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $68.71.

Get Our Latest Report on CVS

CVS Health Stock Performance

Shares of NYSE:CVS opened at $54.71 on Friday. CVS Health Co. has a 12-month low of $43.56 and a 12-month high of $80.75. The company’s 50 day moving average price is $51.21 and its two-hundred day moving average price is $56.22. The firm has a market cap of $68.84 billion, a PE ratio of 13.88, a PEG ratio of 0.80 and a beta of 0.59. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVSGet Free Report) last announced its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating the consensus estimate of $1.08 by $0.01. The firm had revenue of $95.43 billion during the quarter, compared to analysts’ expectations of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The company’s quarterly revenue was up 6.3% compared to the same quarter last year. During the same period in the previous year, the firm earned $2.21 EPS. Equities research analysts predict that CVS Health Co. will post 5.22 earnings per share for the current year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd will be issued a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 4.86%. The ex-dividend date of this dividend is Thursday, January 23rd. CVS Health’s dividend payout ratio is currently 67.51%.

CVS Health Profile

(Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Read More

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVSFree Report).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.